Robert Heidel

Professor of Biostatistics

University of Tennessee Graduate School of Medicine
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (17)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Background People living in Appalachia experience inequities in health outcomes that may result from social determinants of health (SDH) and consequent barriers to healthcare. Objective We aimed to assess SDH in our Appalachian patient population and examine associations between SDH and patients’ physical and emotional well-being. Methods We constructed and administered a SDH questionnaire in an urban medical center in Appalachian East Tennessee. Our survey included administration of the Short Form-36 (SF-36), which measures various domains of physical and emotional health. We used the SDH questionnaire to enumerate respondents’ barriers to health (a total barrier score), with a maximum of 47 barriers identified. Descriptive statistics were calculated as frequencies and percentages. Spearman’s and Pearson’s ( r ) correlations and hierarchical multiple regression models were used to quantify associations between the SDH barrier scores and SF-36 subscales. Results Our patients experienced substantial barriers to health (M = 11.61, SD = 5.10). SDH in our population included being underweight or overweight (BMI < 18.5 or ≥25; 71.2%), having a lower annual family income (<$50,000/year; 60.7%), and experiencing financial difficulty when seeking medical care (51.9%). Some differences in SDH prevalence according to sex were noted, such as a greater proportion of males (12.8%) than females (2.8%) having no health insurance. We observed statistically significant negative correlations between the SDH barriers score and all SF-36 subscales. After controlling for sex, age, and racial group, hierarchical multiple regression models showed a consistent negative relationship between SDH barrier score and all eight SF-36 subscales ( B statistics ranged from −2.04 to −3.66) . Conclusions Patients in our Appalachian population experience a high number of barriers to accessing healthcare that are negatively correlated with measures of physical and emotional well-being. To optimize patient care, assessment of patients’ physical and emotional health should complement the use of SDH questionnaires.

Year:

2025

Background An estimated 10–30% of people with COVID-19 experience debilitating long-term symptoms or long covid. Underlying health conditions associated with chronic inflammation may increase the risk of long covid. Methods We conducted a systematic review and meta-analysis to examine whether long covid risk was altered by pre-existing asthma or chronic obstructive pulmonary disease (COPD) in adults. We identified studies by searching the PubMed and Embase databases from inception to 13 September 2024. We excluded studies that focused on children or defined long covid only in terms of respiratory symptoms. We used random-effects, restricted maximum likelihood models to analyse data pooled from 51 studies, which included 43 analyses of asthma and 30 analyses of COPD. The risk of bias was assessed using a ROBINS-E table. Results We found 41% increased odds of long covid with pre-existing asthma (95% CI 1.29 to 1.54); pre-existing COPD was associated with 32% increased odds (95% CI 1.16 to 1.51). Pre-existing asthma, but not COPD, was associated with increased odds of long covid-associated fatigue. We observed heterogeneity in the results of studies of asthma related to hospitalisation status. Potential confounding and inconsistent measurement of exposure and outcome variables were among the identified limitations. Conclusions Our findings support the hypothesis that pre-existing asthma and COPD increase the risk of long covid, including chronic fatigue outcomes in patients with asthma. Because COVID-19 targets the respiratory tract, these inflammatory conditions of the lower respiratory tract could provide mechanistic clues to a common pathway for the development of long-term sequelae in patients with long covid.

Year:

2025

Background This study analyzed the overall incidence of delirium, comorbid conditions, injury patterns, and pharmacological risk factors for the development of delirium in an alert, geriatric trauma population. Methods IRB-approved, prospective, consecutive cohort series at two Southeastern Level 1 trauma centers from June 11 to August 15, 2023. Delirium was assessed using the Confusion Assessment Method (CAM) score. Comorbidities and medications were detailed from electronic medical records. Inclusion criteria: age ≥55, GCS ≥14, and ICU admission for trauma. Patients on a ventilator were excluded. Data was analyzed using SPSS version 28 (Armonk, NY: IBM Corp). Results In total, 196 patients met inclusion criteria. Incidences of delirium for Hospital 1 (n = 103) and Hospital 2 (n = 93) were 15.5% and 12.9%, respectively, with an overall incidence of 14.3% and with no statistical differences between hospitals ( P = .599). CAD, CKD, dementia, stroke history, and depression were statistically significant risk factors for developing delirium during ICU admission. Inpatient SSRI/SNRIs, epinephrine/norepinephrine, and lorazepam were significant risk factors. Injury patterns, operative intervention, and use of lidocaine infusions and gabapentin were not statistically significant in delirium development. Using binary linear regression (BLR) analysis, independent risk factors for delirium were dementia, any stage CKD, home SSRI/SRNI prescription, any spine injury and cerebrovascular disease, or injury. Discussion Comorbidities of CAD, CHF, CKD, and depression, and these medications: home lorazepam and ICU epinephrine/norepinephrine statistically are more common in patients developing delirium. Dementia, CKD, home SSRI/SRNI and stroke/cerebrovascular disease/injury, and spine injuries are independent predictors by BLR.

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (9)

William Dabbs

Sr. Asst. Dean, Clinical Curriculum

University of Tennessee Health Science Center

UNITED STATES
View details

Shaunta Chamberlin

Professor

University of Tennessee Graduate School of Medicine

UNITED STATES
View details

Alexandria Q. Wilson

Associate Professor

-

UNITED STATES
View details

Paul Terry

Associate Professor (Reseach / Epidemiology)

University of Tennessee Medical Center

UNITED STATES
View details

John E. Griepentrog

Assistant Professor of Surgery

University of Tennessee Medical Center

UNITED STATES
View details

Kelsey Grabeel

Head of Community Health Information Services

University of Tennessee Graduate School of Medicine

UNITED STATES
View details

Jonathan S. Wall

Distinguished Professor

University of Tennessee Graduate School of Medicine

UNITED STATES
View details

Alexander Cavalea

Assistant Professor

University of Tennessee Medical Center

UNITED STATES
View details

Nate Brophy

Graduate Lecturer

George Mason University

UNITED STATES
View details